Siemens Healthineers AG (OTCMKTS:SMMNY) Sees Significant Decline in Short Interest

Siemens Healthineers AG (OTCMKTS:SMMNY) was the recipient of a significant decrease in short interest during the month of October. As of October 30th, there was short interest totaling 7,112 shares, a decrease of 89.8% from the October 15th total of 69,756 shares. Based on an average daily volume of 66,210 shares, the short-interest ratio is currently 0.1 days.

Analysts Set New Price Targets

A number of research firms have recently commented on SMMNY. Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a report on Tuesday, October 13th. Royal Bank Of Canada reissued an “outperform” rating on shares of Siemens Healthineers in a report on Friday, October 16th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Siemens Healthineers in a research report on Tuesday, August 18th. Finally, Zacks Research lowered Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 1st. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Siemens Healthineers Trading Up 0.0%

OTCMKTS:SMMNY traded up $0.01 during trading hours on Wednesday, reaching $24.09. The company had a trading volume of 10,084 shares, compared to its average volume of 125,778. The business’s 50-day simple moving average is $22.64 and its two-hundred day simple moving average is $21.93. Siemens Healthineers has a twelve month low of $19.20 and a twelve month high of $27.46.

About Siemens Healthineers

Siemens Healthineers AG is a Germany-based medical technology company that develops products, services and digital solutions for healthcare providers. Its portfolio supports diagnostic, therapeutic and monitoring activities across hospitals, clinics, laboratories and other healthcare settings. The company’s offerings include magnetic resonance imaging, computed tomography, X-ray, molecular imaging and ultrasound systems, as well as laboratory diagnostics, point-of-care testing and related software.